Advertisement
U.S. Markets closed

Singular Genomics Systems, Inc. (OMIC)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Visitors trend2W10W9M
21.42+0.02 (+0.09%)
At close: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close21.40
Open21.40
Bid0.00 x 0
Ask0.00 x 0
Day's Range21.40 - 22.15
52 Week Range5.34 - 23.41
Volume10,536
Avg. Volume109,100
Market Cap53.802M
Beta (5Y Monthly)1.51
PE Ratio (TTM)N/A
EPS (TTM)-34.68
Earnings DateNov 12, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.45
  • Associated Press Finance

    Similar Genomics Systems: Q3 Earnings Snapshot

    SAN DIEGO (AP) — Singular Genomics Systems Inc. OMIC) on Tuesday reported a loss of $16.8 million in its third quarter. The San Diego-based company said it had a loss of $6.72 per share.

  • GlobeNewswire

    Singular Genomics Reports Recent Updates and Third Quarter 2024 Financial Results

    SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the third quarter ended September 30, 2024. “In the third quarter, we made significant progress in the development of the G4X spatial sequencer,” said Drew Spaventa, Chairman and Chief Exec